Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe
Not Applicable
Completed
- Conditions
- ValveAtrial Fibrillation
- Interventions
- Device: Cryomaze procedure using ArgonDevice: Cryomaze procedure using Nitrous oxide
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01812356
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Phase IV Study to Evaluate the Efficacy and Safety of Mircera in PD
Phase 4
- Conditions
- PD
- Interventions
- Drug: Mircera
- First Posted Date
- 2013-03-08
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 101
- Registration Number
- NCT01807481
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
Phase 2
- Conditions
- NeuroblastomaSoft Tissue SarcomaEwing SarcomaRhabdomyosarcomaOsteosarcoma
- Interventions
- Procedure: haploidentical stem cell transplantation and NK cell therapy
- First Posted Date
- 2013-03-08
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01807468
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Pazopanib Maintenance for SCLC
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 97
- Registration Number
- NCT01797874
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
STRATEGY for Left Main Coronary Bifurcation Lesion II
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: One stent technique + Elective FKBDevice: Elective 2-stentProcedure: Provisional approachDevice: One stent technique alone
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2019-01-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01798433
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma
Completed
- Conditions
- Malignant LymphomaP13K-AKT Pathway Deregulation
- Interventions
- Other: p-AKT immunohistochemical staining
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 262
- Registration Number
- NCT01789060
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction
Phase 4
- Conditions
- Ureteral Obstruction
- Interventions
- Device: cSEMS(Covered self-expandable dual-layered metal stent) implant
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT01788865
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of
Effect of Steroid Injection Which is Added to Percutaneous Trigger Finger Release: a Double-blinded Randomized Controlled Trial.
Not Applicable
Completed
- Conditions
- Trigger Finger
- Interventions
- Procedure: Steroid injection
- First Posted Date
- 2013-01-31
- Last Posted Date
- 2015-05-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 112
- Registration Number
- NCT01781130
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Not Applicable
- Conditions
- EGFR Mutation Positive Non-small Cell Lung Cancer
- Interventions
- Drug: EGFR TKIs (gefitinib, erlotinib, afatinib, et al)
- First Posted Date
- 2013-01-28
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01776684
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image
- First Posted Date
- 2013-01-16
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 70
- Registration Number
- NCT01769482
- Locations
- π°π·
Korea University Guro Hospital, Seoul, Korea, Republic of
π°π·Seoul National University Bundang Hospital, Seongnam, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath